NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF
The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their product...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ROKS, ANTONIUS JACOBUS MARINUS DE VRIES, LOUWE NELEMANS, SIEGER ADRIAAN MOLL, GERT NIKOLAAS RINK, RICK |
| description | The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
L'invention concerne de nouveaux peptides pharmaceutiquement utiles, en particulier des peptides cycliques qui, sont des agonistes du récepteur de l'AngII de type 2 (récepteur AT2). L'invention concerne en outre l'utilisation de tels peptides en tant que médicaments, des compositions pharmaceutiques les contenant, et leur production. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2818299C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2818299C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2818299C3</originalsourceid><addsrcrecordid>eNrjZHD08w9z9VFw9HP39A9x9Qv29FMIiQxwVTBS0HAMMdJUCHJ1dg0I8Q9ScHT39_MMDgkGKnVRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhaGFkaWls7GhFUAAACxKbc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><source>esp@cenet</source><creator>ROKS, ANTONIUS JACOBUS MARINUS ; DE VRIES, LOUWE ; NELEMANS, SIEGER ADRIAAN ; MOLL, GERT NIKOLAAS ; RINK, RICK</creator><creatorcontrib>ROKS, ANTONIUS JACOBUS MARINUS ; DE VRIES, LOUWE ; NELEMANS, SIEGER ADRIAAN ; MOLL, GERT NIKOLAAS ; RINK, RICK</creatorcontrib><description>The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
L'invention concerne de nouveaux peptides pharmaceutiquement utiles, en particulier des peptides cycliques qui, sont des agonistes du récepteur de l'AngII de type 2 (récepteur AT2). L'invention concerne en outre l'utilisation de tels peptides en tant que médicaments, des compositions pharmaceutiques les contenant, et leur production.</description><language>eng ; fre</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181204&DB=EPODOC&CC=CA&NR=2818299C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181204&DB=EPODOC&CC=CA&NR=2818299C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROKS, ANTONIUS JACOBUS MARINUS</creatorcontrib><creatorcontrib>DE VRIES, LOUWE</creatorcontrib><creatorcontrib>NELEMANS, SIEGER ADRIAAN</creatorcontrib><creatorcontrib>MOLL, GERT NIKOLAAS</creatorcontrib><creatorcontrib>RINK, RICK</creatorcontrib><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><description>The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
L'invention concerne de nouveaux peptides pharmaceutiquement utiles, en particulier des peptides cycliques qui, sont des agonistes du récepteur de l'AngII de type 2 (récepteur AT2). L'invention concerne en outre l'utilisation de tels peptides en tant que médicaments, des compositions pharmaceutiques les contenant, et leur production.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD08w9z9VFw9HP39A9x9Qv29FMIiQxwVTBS0HAMMdJUCHJ1dg0I8Q9ScHT39_MMDgkGKnVRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhaGFkaWls7GhFUAAACxKbc</recordid><startdate>20181204</startdate><enddate>20181204</enddate><creator>ROKS, ANTONIUS JACOBUS MARINUS</creator><creator>DE VRIES, LOUWE</creator><creator>NELEMANS, SIEGER ADRIAAN</creator><creator>MOLL, GERT NIKOLAAS</creator><creator>RINK, RICK</creator><scope>EVB</scope></search><sort><creationdate>20181204</creationdate><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><author>ROKS, ANTONIUS JACOBUS MARINUS ; DE VRIES, LOUWE ; NELEMANS, SIEGER ADRIAAN ; MOLL, GERT NIKOLAAS ; RINK, RICK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2818299C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>ROKS, ANTONIUS JACOBUS MARINUS</creatorcontrib><creatorcontrib>DE VRIES, LOUWE</creatorcontrib><creatorcontrib>NELEMANS, SIEGER ADRIAAN</creatorcontrib><creatorcontrib>MOLL, GERT NIKOLAAS</creatorcontrib><creatorcontrib>RINK, RICK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROKS, ANTONIUS JACOBUS MARINUS</au><au>DE VRIES, LOUWE</au><au>NELEMANS, SIEGER ADRIAAN</au><au>MOLL, GERT NIKOLAAS</au><au>RINK, RICK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF</title><date>2018-12-04</date><risdate>2018</risdate><abstract>The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
L'invention concerne de nouveaux peptides pharmaceutiquement utiles, en particulier des peptides cycliques qui, sont des agonistes du récepteur de l'AngII de type 2 (récepteur AT2). L'invention concerne en outre l'utilisation de tels peptides en tant que médicaments, des compositions pharmaceutiques les contenant, et leur production.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2818299C |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A16%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROKS,%20ANTONIUS%20JACOBUS%20MARINUS&rft.date=2018-12-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2818299C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |